スポンサーリンク
Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd. | 論文
- The Chondroprotective Agent ITZ-1 Inhibits Interleukin-1β-Induced Matrix Metalloproteinase-13 Production and Suppresses Nitric Oxide-Induced Chondrocyte Death
- Vagus-Dependent and Vagus-Independent Mechanisms of Action of the Erythromycin Derivative EM574 and Motilin in Dogs
- Absence of Interactive Effects of trans-1,2-Cyclohexanediol,a Major Metabolite of the Side-Chain of Candesartan Cilexetil,on Digoxin-Induced Arrhythmias in Dogs
- Potent NK_1 Receptor Antagonists : Synthesis and Antagonistic Activity of Various Heterocycles with an N-[3,5-Bis(trifluoromethyl)benzyl]-N-methylcarbamoyl Substituent
- A New Chondrogenic Differentiation Initiator With the Ability to Up-Regulate SOX Trio Expression
- Discovery of a Potent and Orally Available Acyl-CoA: Cholesterol Acyltransferase Inhibitor as an Anti-atherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives
- Regional Hemodynamic Effects of Candesartan Cilexetil (TCV : 116),an Angiotensin II AT_1 : Receptor Antagonist,in Conscious Spontaneously Hypertensive Rats
- Combined Effects of the Angiotensin II Antagonist Candesartan Cilexetil (TCV-116) and Other Classes of Antihypertensive Drugs in Spontaneously Hypertensive Rats
- Discovery of a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: The Synthesis, Biological Evaluation, and Reduced Adrenal Toxicity of (4-Phenylcoumarin)acetanilide Derivatives with a Carboxylic Acid Moiety